Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables BLOOD Roberts, A. W., Ma, S., Kipps, T. J., Coutre, S. E., Davids, M. S., Eichhorst, B., Hallek, M., Byrd, J. C., Humphrey, K., Zhou, L., Chyla, B., Nielsen, J., Potluri, J., Kim, S., Verdugo, M., Stilgenbauer, S., Wierda, W. G., Seymour, J. F. 2019; 134 (2): 111–22
View details for DOI 10.1182/blood.2018882555
View details for Web of Science ID 000474864100008